Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-09-22FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for donepezil hydrochloride (generic) by Macleods Pharmaceuticals Limited, authorizing its marketing…
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: Alzheimer's Disease - Input of Vitamin D With mEmantine Assay [Phase 3]
A Phase 3 clinical trial evaluating the addition of Vitamin D to memantine for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: Gait and Alzheimer Interaction Tracking (GAIT) Study
The GAIT study conducted at University Hospital Angers has completed, focusing on gait apraxia in the context of Alzheimer’s disease and rel…
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Support by Singing Sessions on Physical and Moral Pain : Assessment of Its Effectiveness in Alzheimer's Disease [NA]
A completed clinical trial evaluated whether singing sessions can alleviate physical and moral pain in people with Alzheimer's disease. The …
-
CLINICAL_TRIALS research · 2016-09-13Clinical Trial Update: Pre-Clinical (Alzheimers) Diagnosis PCD = Optimum Outcomes OO
This entry reports a pre-clinical Alzheimer's diagnostic trial (NCT02835716) sponsored by Millennium Magnetic Technologies, with the trial s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education Program [NA]
A completed clinical trial evaluating Distance Savvy, a distance education program for dementia family caregivers (Tele-Savvy). Emory Univer…
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: Overuse of Antidepressant in Patients With Alzheimer Disease
A completed clinical trial investigating the overuse of antidepressants in patients with Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: The Effect of Repeated Transcranial Magnetic Stimulation on Off-line Resting Electroencephalographic Signal in Alzheimer's Disease [NA]
The clinical trial evaluating the effect of repeated transcranial magnetic stimulation on off-line resting EEG in Alzheimer's disease has be…
-
FDA approval · 2016-08-25FDA Approved: NEURACEQ — Supplemental Application (Lantheus Biosciences Ltd.)
The FDA approved a supplemental application for NEURACEQ (florbetaben F-18) submitted by Lantheus Biosciences Ltd.
-
CLINICAL_TRIALS trial_result · 2016-08-23Clinical Trial Update: Long-Term Study of IGIV, 10% in Alzheimer´s Disease [Phase 3]
Phase 3 long-term study of 10% intravenous immunoglobulin (IGIV) in Alzheimer's disease was terminated; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-08-23Clinical Trial Update: Construction of Diagnosis System for Early AD Based on Multi-Modality MRI Technology
A completed clinical trial evaluated a multi-modality MRI-based system for diagnosing Alzheimer's disease at an early stage, including indiv…
-
CLINICAL_TRIALS trial_result · 2016-08-22Clinical Trial Update: Conservation of Praxis in the Food and Alzheimer Disease
A clinical trial in Alzheimer's disease conducted at University Hospital, Limoges has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline [Phase 4]
Phase 4 trial results examine how Florbetapir (18F) PET imaging changes patient management in Alzheimer's disease and explore the relationsh…
-
CLINICAL_TRIALS trial_result · 2016-08-16Clinical Trial Update: S-Equol in Alzheimer's Disease (SEAD) Trial [Phase 1]
This update notes the completion of the Phase 1 SEAD trial evaluating S-Equol for Alzheimer's disease.
-
CLINICAL_TRIALS research · 2016-08-16Clinical Trial Update: Identification of Epigenetic Markers Common to Obesity and Alzheimer's Disease in Women [NA]
A clinical trial update outlines a study aiming to identify epigenetic markers shared by obesity and Alzheimer's disease in women, sponsored…
-
CLINICAL_TRIALS trial_result · 2016-08-15Clinical Trial Update: Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update evaluating the efficacy and safety of ELND005 for agitation and aggression in Alzheimer's disease; study compl…
-
CLINICAL_TRIALS trial_result · 2016-08-11Clinical Trial Update: Sleep Apnea in Early to Mid-Stage Alzheimer's Disease
A clinical trial evaluating sleep apnea in early- to mid-stage Alzheimer's disease has been terminated. The study was sponsored by Centre Ho…
-
CLINICAL_TRIALS research · 2016-08-09Clinical Trial Update: COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE
This is a completed clinical trial update evaluating the comparative effectiveness of treatments for mild cognitive impairment and dementia …
-
FDA approval · 2016-08-05FDA Approved: GALANTAMINE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for a generic Galantamine from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS research · 2016-07-26Clinical Trial Update: Cognitive, Morphological and Neurobiological Progressive Aspects in Bipolar Disorders in the Elderly: Toward to a Neurodegenerescence Detection? [NA]
A clinical trial update examining cognitive, morphological, and neurobiological changes in elderly people with bipolar disorder. It explores…
-
CLINICAL_TRIALS research · 2016-07-22Clinical Trial Update: Enteric Nervous System in Alzheimer Disease [NA]
A Nantes University Hospital-sponsored clinical trial is exploring the enteric nervous system in Alzheimer's disease, but no phase or status…
-
FDA approval · 2016-07-18FDA Approved: NAMZARIC — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for NAMZARIC (memantine hydrochloride and donepezil hydrochloride) from Allergan, Inc.
-
CLINICAL_TRIALS trial_result · 2016-07-15Clinical Trial Update: Exploratory Study for the Validity of QuQu Scale
This update reports the completion of an exploratory study to assess the validity of the QuQu Scale for Alzheimer’s disease.
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter) [Phase 3]
This entry documents a completed Phase 3 safety study of AVP-923 for involuntary emotional expression disorder (pseudobulbar affect). It inv…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training [Phase 4]
A Phase 4 trial evaluated memantine with comprehensive, individualized management of Alzheimer's disease and caregiver training; results wer…